| |
| |
|
| Insider
Information: |
Seely Lynn |
| Relationship: |
President and CEO, Dir... |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,351,530 |
|
|
Indirect Shares
|
846,168 |
|
|
| Direct
Value |
$29,839,560 |
|
|
|
Indirect Value
|
$22,829,613 |
|
|
| Total
Shares |
2,197,698 |
|
|
| Total
Value |
$52,669,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
Chief Medical Officer |
2015-02-09 |
96,694 |
2007-03-16 |
0 |
Premium* |
|
|
Myovant Sciences Ltd. |
MYOV |
Principal Executive Of... |
2020-04-03 |
1,043,824 |
2020-04-03 |
846,168 |
Premium* |
|
|
Blueprint Medicines Corp |
BPMC |
|
2023-06-21 |
11,012 |
2020-06-19 |
0 |
Premium* |
|
|
Lyell Immunopharma, Inc. |
LYEL |
President and CEO, Dir... |
2024-02-09 |
200,000 |
2024-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-07-22 |
4 |
OE |
$6.74 |
$50,513 |
D/D |
7,500 |
66,522 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-08-08 |
4 |
OE |
$9.39 |
$122,005 |
D/D |
13,000 |
72,022 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-08-12 |
4 |
OE |
$9.39 |
$117,313 |
D/D |
12,500 |
71,522 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-08-13 |
4 |
OE |
$6.74 |
$167,825 |
D/D |
20,000 |
79,022 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-08-26 |
4 |
OE |
$10.59 |
$60,335 |
D/D |
5,700 |
64,722 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-08-27 |
4 |
OE |
$10.59 |
$151,366 |
D/D |
14,300 |
73,322 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-09-09 |
4 |
OE |
$10.59 |
$211,700 |
D/D |
20,000 |
79,022 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-09-17 |
4 |
OE |
$6.74 |
$253,800 |
D/D |
30,000 |
89,022 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-09-18 |
4 |
OE |
$10.59 |
$264,625 |
D/D |
25,000 |
84,022 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-10-15 |
4 |
OE |
$6.74 |
$194,737 |
D/D |
24,346 |
84,200 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-10-16 |
4 |
OE |
$10.59 |
$52,925 |
D/D |
5,000 |
64,854 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-10-22 |
4 |
OE |
$10.59 |
$52,925 |
D/D |
5,000 |
64,854 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-12-19 |
4 |
OE |
$9.39 |
$318,949 |
D/D |
31,340 |
91,194 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-06-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,312 |
1,312 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-10-15 |
4 |
S |
$87.61 |
$2,169,363 |
D/D |
(24,346) |
59,854 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Medical Officer |
• – – |
2014-10-16 |
4 |
S |
$93.97 |
$469,850 |
D/D |
(5,000) |
59,854 |
0 |
- |
|
91 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
